Nalaganje...
Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes
Worldwide statins are considered to be the first-line pharmacological treatment for dyslipidemia and reducing the risk of coronary heart disease. However, recently various studies have shown its adverse effect on glucose control among diabetic patients and the U.S. Food and Drug Administration have...
Shranjeno v:
| izdano v: | Int J Angiol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Thieme Medical Publishers
2018
|
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6103774/ https://ncbi.nlm.nih.gov/pubmed/30154630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0036-1572523 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|